Valuation · US stocks

Veradermics, Incorporated (MANE) valuation

As of 2026-11-18, Veradermics, Incorporated trades at $124.89, inside its 1-year fair-value range.

Price
$124.89
Day change
-0.79%
Market cap
$5.71B
Sector
Pharmaceuticals: Major
Valuation
Fair
Fair value
Sign up free to see the fair value and gap
As of
2026-11-18
Open the full valuation in Wave Radar

Other Pharmaceuticals: Major stocks

StockPriceMarket capValuation
Eli Lilly and Company LLY$1,382.31$1.27TFair
Johnson & Johnson JNJ$272.72$646.92BAbove band
Merck & Co., Inc. MRK$137.75$366.28BAbove band
AstraZeneca PLC AZN$178.77$289.48BFair
Novo Nordisk A/S Sponsored ADR Class B NVO$39.45$176.43BFair
Pfizer Inc. PFE$28.06$166.61BAbove band
Bristol-Myers Squibb Company BMY$59.56$132.14BFair
Vertex Pharmaceuticals Incorporated VRTX$536.45$132.00BFair
Regeneron Pharmaceuticals, Inc. REGN$945.53$83.42BHigh
Royalty Pharma Plc Class A RPRX$68.67$39.04BAbove band
Biogen Inc. BIIB$251.41$37.49BAbove band
Zoetis, Inc. Class A ZTS$85.57$30.40BBelow band

How the valuation band works

Wave Radar estimates a fair-value range from each company's earnings, book value and its own historical P/E and P/B over 1, 3 and 5-year windows. The 1-year window gives the tight range; the widest bounds across all windows give the loose one. "Low" and "High" mean the price has left the tight range; "Below band" and "Above band" mean it has left even the widest one.

Read the method

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.